Item
VITAMIN B1 (THIAMINE) MONONITRATE (1121)
Thiamine Mononitrate - 98.0-101.0
Nutrient / Vitamin
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| Huazhong Pharmaceuticals Co. Ltd. | No. 118, Xianshan Road Xiangyang City, Hubei Province 441000 CHN |
| Jiangxi Tianxin Pharmaceutical Co., Ltd. | Leping Industrial Zone, Leping City Jingdezhen City, JX 333300 CHN |
| Prinova USA | 6525 Muirfield Drive. Hanover Park, IL 60133 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| HACCP | Prinova USA | 3rd party-Haccp doc - Prinova.pdf | 6/9/2021 | 6/8/2024 |
| HACCP | Jiangxi Tianxin Pharmaceutical Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 5/18/2022 | 5/17/2025 |
| HACCP | Huazhong Pharmaceuticals Co. Ltd. | 3rd party-Haccp doc - Prinova.pdf | 5/18/2022 | 5/17/2025 |
| Gluten | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Allergen - 2024-01-05T144202.948.pdf | 12/4/2023 | 12/3/2024 |
| Allergens EU/UK | Huazhong Pharmaceuticals Co. Ltd. | Allergens EU/UK.pdf | 11/22/2022 | 11/21/2024 |
| Allergens | Huazhong Pharmaceuticals Co. Ltd. | Allergens.pdf | 6/13/2023 | 6/12/2025 |
| Allergens | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Allergens.pdf | 2/14/2025 | 2/14/2027 |
| CoA Sample | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Approved COA Template - 2024-01-05T143035.711.pdf | 10/1/2023 | 9/30/2025 |
| CoA Sample | Huazhong Pharmaceuticals Co. Ltd. | Approved COA Template - 2025-01-16T144531.590.pdf | 6/27/2024 | 6/27/2026 |
| WADA/NSF/NFL Statement | Huazhong Pharmaceuticals Co. Ltd. | Banned Substance (26).pdf | 6/10/2022 | 6/10/2025 |
| Heavy Metal | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2024-01-05T143522.231.pdf | 12/4/2023 | 12/3/2025 |
| Melamine | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2024-01-05T143522.231.pdf | 12/4/2023 | 12/3/2024 |
| Pesticide | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2024-01-05T143522.231.pdf | 12/4/2023 | 12/3/2025 |
| Residual Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2024-01-05T143522.231.pdf | 12/4/2023 | 12/3/2024 |
| Heavy Metal | Huazhong Pharmaceuticals Co. Ltd. | Contaminants and Impurities - 2025-01-16T143915.370.pdf | 6/27/2024 | 6/27/2026 |
| Pesticide | Huazhong Pharmaceuticals Co. Ltd. | Contaminants and Impurities - 2025-01-16T143915.370.pdf | 6/27/2024 | 6/27/2026 |
| Melamine | Huazhong Pharmaceuticals Co. Ltd. | Contaminants and Impurities (66).pdf | 7/30/2022 | 7/30/2023 |
| Residual Statement | Huazhong Pharmaceuticals Co. Ltd. | Contaminants and Impurities (82).pdf | 7/30/2022 | 7/30/2023 |
| Country of Origin EU/UK | Huazhong Pharmaceuticals Co. Ltd. | Country of Origin EU/UK.pdf | 11/22/2022 | 11/21/2025 |
| Country of Origin | Huazhong Pharmaceuticals Co. Ltd. | Country of Origin.pdf | 11/22/2022 | 11/21/2025 |
| Country of Origin | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Country of Origin.pdf | 1/16/2025 | 1/16/2028 |
| HACCP Process Flow Diagram | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Flow Chart - 2024-01-05T144259.435.pdf | 12/13/2023 | 12/12/2025 |
| HACCP Process Flow Diagram | Huazhong Pharmaceuticals Co. Ltd. | Flow Chart - 2025-01-16T135243.620.pdf | 8/1/2024 | 8/1/2026 |
| FSVP Assessment Form | Jiangxi Tianxin Pharmaceutical Co., Ltd. | FSVP Assessment Form.pdf | 1/31/2025 | 1/31/2026 |
| FSVP Assessment Form | Huazhong Pharmaceuticals Co. Ltd. | FSVP Assessment Form.pdf | 2/5/2025 | 2/5/2026 |
| GMO | Jiangxi Tianxin Pharmaceutical Co., Ltd. | GMO - 2025-01-16T134707.344.pdf | 8/9/2024 | 8/9/2026 |
| GMO | Huazhong Pharmaceuticals Co. Ltd. | GMO - 2025-01-16T143240.586.pdf | 6/27/2024 | 6/27/2026 |
| Halal | Huazhong Pharmaceuticals Co. Ltd. | Halal Certificate - 2023-05-15T112608.925.pdf | 8/18/2022 | 8/17/2026 |
| Halal | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Halal Certificate (172).pdf | 12/15/2021 | 12/15/2025 |
| Item Questionnaire | Huazhong Pharmaceuticals Co. Ltd. | Item Questionnaire.pdf | 12/12/2022 | 12/11/2025 |
| Item Questionnaire | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Item Questionnaire.pdf | 4/10/2025 | 4/9/2028 |
| Kosher | Prinova USA | Kosher Certificate - 2023-05-15T085451.032.pdf | 4/30/2023 | 4/30/2024 |
| Kosher | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Kosher Certificate - 2023-10-11T095428.231.pdf | 7/23/2023 | 6/30/2026 |
| Kosher | Huazhong Pharmaceuticals Co. Ltd. | Kosher Certificate - 2025-05-09T133411.135.pdf | 3/28/2025 | 4/30/2026 |
| National Bioengineered Food Disclosure Standard (Simplified) | Huazhong Pharmaceuticals Co. Ltd. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 11/22/2022 | 11/21/2025 |
| Vegan/Vegetarian Statement | Huazhong Pharmaceuticals Co. Ltd. | NotApplicable_VeganVegetarianStatement.pdf | 10/2/2023 | 10/1/2025 |
| Nutrition | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Nutrition.pdf | 1/24/2025 | 1/24/2028 |
| Nutrition | Huazhong Pharmaceuticals Co. Ltd. | Nutrition.pdf | 4/10/2025 | 4/9/2028 |
| Irradiation Status Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Organic Compliance - 2024-01-05T142805.202.pdf | 12/6/2023 | 12/5/2025 |
| Natural | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Organic Compliance - 2024-01-05T142805.202.pdf | 12/6/2023 | 12/5/2024 |
| Organic | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Organic Compliance - 2024-01-05T144404.798.pdf | 12/6/2023 | 12/6/2026 |
| Irradiation Status Statement | Huazhong Pharmaceuticals Co. Ltd. | Organic Compliance - 2024-01-31T144552.786.pdf | 11/17/2022 | 11/16/2024 |
| Sewage Statement | Huazhong Pharmaceuticals Co. Ltd. | Organic Compliance - 2024-01-31T144552.786.pdf | 11/17/2022 | 11/16/2024 |
| EtO Statement | Huazhong Pharmaceuticals Co. Ltd. | Organic Compliance (30).pdf | 11/17/2021 | 11/17/2024 |
| Organic | Huazhong Pharmaceuticals Co. Ltd. | Organic Compliance (30).pdf | 11/17/2021 | 11/17/2024 |
| Natural | Huazhong Pharmaceuticals Co. Ltd. | Organic Compliance (49).pdf | 11/17/2022 | 11/17/2023 |
| Label Sample | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Packaging Declaration - 2024-01-05T143205.296.pdf | 12/4/2023 | 12/3/2024 |
| Lot Code | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Packaging Declaration - 2024-01-05T143205.296.pdf | 12/4/2023 | 12/3/2026 |
| Food Contact Packaging Certificate of Compliance | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Packaging Declaration - 2024-01-05T143205.296.pdf | 12/4/2023 | 12/3/2025 |
| Lot Code | Huazhong Pharmaceuticals Co. Ltd. | Packaging Declaration - 2025-01-16T143124.933.pdf | 6/27/2025 | 6/26/2028 |
| Label Sample | Huazhong Pharmaceuticals Co. Ltd. | Packaging Declaration (63).pdf | 7/27/2022 | 7/27/2023 |
| California Prop. 65 | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Product Data Sheet - 2024-01-05T145219.290.pdf | 12/13/2023 | 12/12/2025 |
| Ingredient Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Product Data Sheet - 2024-01-05T145219.290.pdf | 12/13/2023 | 12/12/2024 |
| California Prop. 65 | Huazhong Pharmaceuticals Co. Ltd. | Product Data Sheet - 2025-01-07T110424.201.pdf | 6/27/2024 | 6/27/2026 |
| BSE - TSE | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2024-01-05T143814.335.pdf | 12/4/2023 | 12/3/2026 |
| No Animal Ingredient Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2024-01-05T143814.335.pdf | 12/4/2023 | 12/3/2024 |
| Vegan/Vegetarian Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2024-01-05T143814.335.pdf | 12/4/2023 | 12/3/2026 |
| GRAS/NDI/ODI Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2025-01-16T130749.769.pdf | 8/9/2023 | 8/8/2026 |
| BSE - TSE | Huazhong Pharmaceuticals Co. Ltd. | Regulatory Information Sheet (105).pdf | 7/30/2021 | 7/29/2024 |
| Gluten | Huazhong Pharmaceuticals Co. Ltd. | Regulatory Information Sheet.pdf | 8/1/2023 | 7/31/2024 |
| Safety Data Sheet (SDS) | Huazhong Pharmaceuticals Co. Ltd. | SDS - 2023-12-28T143327.500.pdf | 10/23/2023 | 10/22/2025 |
| Safety Data Sheet (SDS) | Jiangxi Tianxin Pharmaceutical Co., Ltd. | SDS - 2025-01-16T134451.457.pdf | 8/9/2023 | 8/8/2026 |
| Product Specification Sheet | Huazhong Pharmaceuticals Co. Ltd. | Specification - Factory - 2025-01-16T142731.992.pdf | 6/27/2024 | 6/27/2027 |
| Shelf Life | Huazhong Pharmaceuticals Co. Ltd. | Specification - Factory 6.pdf | 7/29/2021 | 7/28/2024 |
| Suitability Requirements | Huazhong Pharmaceuticals Co. Ltd. | Suitability Requirements.pdf | 10/26/2022 | 10/25/2025 |
| Suitability Requirements | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Suitability Requirements.pdf | 3/22/2023 | 3/21/2026 |
| GRAS/NDI/ODI Statement | Huazhong Pharmaceuticals Co. Ltd. | US Regulatory Status (31).pdf | 11/28/2022 | 11/28/2025 |
| Shelf Life | Jiangxi Tianxin Pharmaceutical Co., Ltd. | US SPECIFICATION - 2024-01-05T144035.147.pdf | 12/15/2023 | 12/14/2025 |
| Product Specification Sheet | Jiangxi Tianxin Pharmaceutical Co., Ltd. | US SPECIFICATION - 2025-01-16T134354.976.pdf | 12/15/2023 | 12/14/2026 |
